Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Metastasis02:30

Metastasis

6.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tunable Palladium-Catalyzed [2π + 2σ] Cycloaddition/Alder-Ene Reactions of Vinylbicyclo[1.1.0]butanes with Cyclic <i>N</i>-Sulfonylimines.

The Journal of organic chemistry·2026
Same author

Correction: <sup>1</sup>H-NMR serum metabolomic profiling from clinical routine identifies signatures of progressive melanoma metastasis.

Scientific reports·2026
Same author

A dietary switch promotes sensory neuron-dependent cancer-associated cachexia.

Science (New York, N.Y.)·2026
Same author

Regular Aerobic Exercise Can Effectively Ameliorate the Skeletal Muscle and Mitochondrial Function Impairments Caused by <i>bves</i> Deficiency in Zebrafish.

International journal of molecular sciences·2026
Same author

Regular exercise improves cardiac dysfunction in Drosophila by inhibiting excessive mitochondrial fission through RalA.

Biochimica et biophysica acta. Molecular basis of disease·2026
Same author

A membrane homeostatic response to lipid overload coordinates fatty acid metabolism.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Jan 12, 2026

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
07:45

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis

Published on: January 26, 2024

2.7K

Lymph node environment drives FSP1 targetability in metastasizing melanoma.

Mario Palma1, Milena Chaufan1, Cort B Breuer2,3

  • 1Department of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Nature
|November 5, 2025
PubMed
Summary
This summary is machine-generated.

Targeting ferroptosis suppressor protein 1 (FSP1) effectively inhibits melanoma growth in lymph nodes by exploiting a metabolic shift in metastatic cells. This approach offers a new therapeutic window for treating advanced melanoma.

More Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.8K
Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
08:18

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma

Published on: September 8, 2021

3.3K

Related Experiment Videos

Last Updated: Jan 12, 2026

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
07:45

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis

Published on: January 26, 2024

2.7K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.8K
Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
08:18

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma

Published on: September 8, 2021

3.3K

Area of Science:

  • Oncology
  • Cancer Metastasis
  • Cellular Metabolism

Background:

  • Ferroptosis is a key target for overcoming therapy-resistant and metastatic cancers.
  • Glutathione peroxidase 4 (GPX4) inhibits ferroptosis in hematogenous metastasis but is not essential for lymphatic metastasis in melanoma.
  • The specific ferroptosis surveillance systems that can be therapeutically leveraged in cancer remain largely unknown.

Purpose of the Study:

  • To investigate the ferroptosis mechanisms and metabolic adaptations of melanoma cells during lymphatic metastasis.
  • To identify potential therapeutic targets within the lymphatic metastatic niche.

Main Methods:

  • Utilized a metastatic mouse melanoma model selected for lymph node metastasis.
  • Analyzed gene expression, protein levels, and metabolite concentrations (glutathione) in metastatic cells.
  • Investigated the role of GPX4 and FSP1 in ferroptosis regulation under hypoxic conditions.
  • Assessed the efficacy of FSP1 inhibitors (viFSP1, FSEN1) in vivo.

Main Results:

  • Melanoma cells in the lymphatic niche showed decreased glutamate-cysteine ligase (GCLC) and glutathione (GSH) levels.
  • Hypoxia induced GPX4 ubiquitination and degradation, leading to increased reliance on FSP1.
  • FSP1 inhibitors suppressed melanoma growth specifically in lymph node tumors, not subcutaneous tumors.
  • This highlights a microenvironment-specific dependency on FSP1 in lymph node metastases.

Conclusions:

  • Reduced GPX4 activity allows melanoma cells to depend on FSP1 for survival in the hypoxic lymphatic niche.
  • Targeting FSP1 in lymph nodes presents a promising strategy for blocking melanoma progression.
  • FSP1 inhibition demonstrates potential as a targeted therapy for lymph node-positive melanoma.